Biosecure Act left out of Senate NDAA vote

Biotechnology

Sep 29, 2024

Good morning,

These weekend editions are generally going to be shorter than the weekday ones as they are more focused directly on a specific deep tech sector and leave out some of the other news. Having said that, there’s plenty to discuss in terms of biotech this week.

Let’s go!

Biotechnology News Headlines:

Biosecure Act left out of Senate defense spending bill vote, seen as most likely path to a floor vote (AX)
Fundraising in Biotech has gotten harder (MCN)
PE has soured on European biotech (PB)
Endpoints News announces 2024 Winners of the Endpoints 11 Awards, highlighting Biotech's most promising startups (BW)
UK-based LinkGevity receives Horizon Europe's Women TechEU grant to continue AI-driven drug discovery to combat age-related diseases (YF)
10 Areas where AR/VR can impact healthcare (HD)
Synthetic biology market to grow by $55.6Bn by 2028, driven by AI (PRN)
The value of HealthTech exits has more than tripled in 2024 compared to last year (AX)
AI boom set to revolutionize healthcare in Europe (PhT)
Integrated DNA Technologies unveils new lymphoma panel to enhance blood cancer research (BW)
Healthy.io lays off another 30% of team in second major restructuring (CT)
Multiply Labs announces a collaboration on automating cell therapy manufacturing with Legend Biotech (BW)

Deal Flow:

ARCH Venture Partners closes over $3B biotech fund (CB)
Asabys Partners, a Barcelona-based VC firm, raised $201.3M for its second fund focused on biopharma, medtech, and digital health companies (EBT)
UK-based Vicebio raises $100M in Series B funding led by TCGX for next-gen vaccines for respiratory viruses (TNW)
Mendaera, a Bay Area startup building robots for medical use, raised a $73M Series B, led by Threshold Ventures (BW)
GC Therapeutics, a five-year-old Boston startup focused on using induced pluripotent stem cells to create off-the-shelf treatments, raised a $65M Series A led by Cormorant Asset Management (PhT)
Indian medical imaging startup Qure.AI raised $65M Series D co-led by Lightspeed and 360 ONE Asset Management (TIA)
Mirai Bio, a startup focused on accelerating the development of gene therapies, raised $50M from Flagship Pioneering (PRN)
Biotech startup 858 Therapeutics, which is working on treatments for cancerous tumors, raised a $50M Series B led by Avidity Partners (BW)
Nvidia's venture arm backs $17M investment in Hippocratic AI to build out generative AI healthcare agents (BW)
a16z makes first 'DeSci' investment, leading decentralized biobank platform AminoChain's $5M seed round (BLK)
DeepLook Medical, a healthtech startup using AI to enhance detection and analysis of suspicious lesions in dense breast tissue, announced its first close of its Series A raise, led by Xcellerant Venture (BW)

BioAge Labs raised $198M in its IPO of 10.5M shares priced at $18 on the Nasdaq (RT)

Opportunities

The Biomedical Advanced Research and Development Authority is seeking [potential contractors to provide coures on considerations required to bring a drug to market (SAM)